Pharmaceutical Industry

letters

POGO and Coalition of Organizations Support Curbing Improper Payments Senate Considers Legislation to Help Stop Improper Payments POGO's Response to VA Inspector General's Subpoena for Whistleblower Records Public Comment on the Potential Release of Medicare Physician Data

Latest

Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

investigation | May 5, 2020

Read

Latest

Following the (Drug) Money

investigation | May 5, 2020

Read

Tainted Prescriptions: Big Pharma's Ties to Experts Advising Congress on Drug Costs

investigation | January 28, 2019
Congress Taking Aim at Waste and Fraud

analysis | June 1, 2018
I See Dead People . . . Cashing Federal Checks; Legislation Targets Payments Made in Error

analysis | February 26, 2018
Strengthening Financial Integrity of Federal Agencies

analysis | June 16, 2017
SEC Secures Another Win for Whistleblower Rights

analysis | August 24, 2016
Addicted to Fraud? Health Care Industry Forced to Return Nearly $2 Billion to Taxpayers Under False Claims Act

report | April 27, 1998